Group structure
8 companies in 3 countries
Loading your page…
8 companies in 3 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
10 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| DULOXETINA GENESIS 30 MG CAPSULAS DURAS GASTRORRESISTENTES EFG33,66 mg · Cápsula dura gastrorresistente | Duloxetine | Spain | Marketed | 2015 |
| DULOXETINA GENESIS 60 MG CAPSULAS DURAS GASTRORRESISTENTES EFG67,320 mg · Cápsula dura gastrorresistente | Duloxetine | Spain | Marketed | 2015 |
| ACTIWIPE0.05 % / w/w · Wipe | Benzalkonium | Canada | Marketed | 2017 |
| BIOTAL W0.05 % / w/w · Wipe | Benzalkonium | Canada | Authorised | |
| ENVIROSAN2.25 % / w/w + 2.25 % / w/w · Liquid | Alkyl dimethyl ethylbenzyl ammonium, Benzalkonium | Canada | Marketed | 2017 |
| HYDREX 1001 % / w/w · Solution | Iodine | Canada | Authorised | |
| HYDREX 500.5 % / w/w · Solution | Iodine | Canada | Authorised | |
| QUATSAN 270 M5 % + 5 % · Liquid | Alkyl dimethyl ethylbenzyl ammonium, Benzalkonium | Canada | Marketed | 2017 |
| MICOFENOLATO DE MOFETILO GENESIS 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG500 mg · Comprimido recubierto con película | Mycophenolate mofetil | Spain | Withdrawn | 2014 |
| OTS ON THE SPOT RTU DISINFECTANT/SANITIZER0.15 % / w/w + 0.15 % / w/w · Solution, Spray | Alkyl dimethyl ethylbenzyl ammonium, Benzalkonium | Canada | Cancelled | 2018 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 7 | 6 | 1 | CompaniesAll medicines |
| Spain | 3 | 2 | 1 | CompaniesAll medicines |
Also in the registers of United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.